Cargando…

SPHK1 regulates proliferation and survival responses in triple-negative breast cancer

Triple-negative breast cancer (TNBC) is characterized by unique aggressive behavior and lack of targeted therapies. Among the various molecular subtypes of breast cancer, it was observed that TNBCs express elevated levels of sphingosine kinase 1 (SPHK1) compared to other breast tumor subtypes. High...

Descripción completa

Detalles Bibliográficos
Autores principales:	Datta, Arpita, Loo, Ser Yue, Huang, Baohua, Wong, Lingkai, Tan, Sheryl S.L., Tan, Tuan Zea, Lee, Soo-Chin, Thiery, Jean Paul, Lim, Yaw Chyn, Yong, Wei Peng, Lam, Yulin, Kumar, Alan Prem, Yap, Celestial T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171602/ https://www.ncbi.nlm.nih.gov/pubmed/25153718

Ejemplares similares

Sphingosine Kinase 1 Promotes Malignant Progression in Colon Cancer and Independently Predicts Survival of Patients With Colon Cancer by Competing Risk Approach in South Asian Population
por: Tan, Sheryl S L, et al.
Publicado: (2014)

Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis
por: Datta, Arpita, et al.
Publicado: (2021)

PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression
por: Deng, Shuo, et al.
Publicado: (2022)

Gelsolin-Cu/ZnSOD interaction alters intracellular reactive oxygen species levels to promote cancer cell invasion
por: Tochhawng, Lalchhandami, et al.
Publicado: (2016)

Gelsolin-mediated activation of PI3K/Akt pathway is crucial for hepatocyte growth factor-induced cell scattering in gastric carcinoma
por: Huang, Baohua, et al.
Publicado: (2016)

Lentivirus-mediated siRNA knockdown of SPHK1 inhibits proliferation and tumorigenesis of neuroblastoma
por: Su, Lin, et al.
Publicado: (2018)

Cytoskeletal Proteins in Cancer and Intracellular Stress: A Therapeutic Perspective
por: Ong, Mei Shan, et al.
Publicado: (2020)

Gelsolin Induces Colorectal Tumor Cell Invasion via Modulation of the Urokinase-Type Plasminogen Activator Cascade
por: Zhuo, Jingli, et al.
Publicado: (2012)

Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget
por: Hatoum, Diana, et al.
Publicado: (2017)

Sphk1 and Sphk2 Differentially Regulate Erythropoietin Synthesis in Mouse Renal Interstitial Fibroblast-like Cells
por: Hafizi, Redona, et al.
Publicado: (2022)

Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers
por: Loo, Ser Yue, et al.
Publicado: (2021)

Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases
por: Bu, Yanhong, et al.
Publicado: (2021)

Putting the BRK on breast cancer: From molecular target to therapeutics
por: Ang, Hui Li, et al.
Publicado: (2021)

Inhibition of SphK1 reduces radiation-induced migration and enhances sensitivity to cetuximab treatment by affecting the EGFR/SphK1 crosstalk
por: Schiefler, Carlotta, et al.
Publicado: (2014)

Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation
por: Dai, Lan, et al.
Publicado: (2022)

SPHK1‐induced autophagy in peritoneal mesothelial cell enhances gastric cancer peritoneal dissemination
por: Yin, Songcheng, et al.
Publicado: (2019)

SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition
por: Sundararajan, Vignesh, et al.
Publicado: (2019)

Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)
por: Huang, Ruby Yun-Ju, et al.
Publicado: (2015)

Activation of SphK1 by adipocytes mediates epithelial ovarian cancer cell proliferation
por: Dai, Lan, et al.
Publicado: (2021)

Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma
por: Chen, Ming-Huang, et al.
Publicado: (2015)

SphK2 over-expression promotes osteosarcoma cell growth
por: Xu, Dawei, et al.
Publicado: (2017)

Design, Synthesis and Biological Activity Testing of Library of Sphk1 Inhibitors
por: Geng, Shuangshuang, et al.
Publicado: (2022)

Cell fate determined by the activation balance between PKR and SPHK1
por: Qiao, Han, et al.
Publicado: (2020)

DNA Methylation Profiling of Breast Cancer Cell Lines along the Epithelial Mesenchymal Spectrum—Implications for the Choice of Circulating Tumour DNA Methylation Markers
por: Le, Anh Viet-Phuong, et al.
Publicado: (2018)

Induction of Sphk1 activity in obese adipose tissue macrophages promotes survival
por: Gabriel, Tanit L., et al.
Publicado: (2017)

Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma
por: Shi, Weiwei, et al.
Publicado: (2020)

SPHK Inhibitors and Zoledronic Acid Suppress Osteoclastogenesis and Wear Particle-Induced Osteolysis
por: Gu, Minghui, et al.
Publicado: (2022)

SphK2/S1P Promotes Metastasis of Triple-Negative Breast Cancer Through the PAK1/LIMK1/Cofilin1 Signaling Pathway
por: Shi, Weiwei, et al.
Publicado: (2021)

Identification of 42 Genes Linked to Stage II Colorectal Cancer Metastatic Relapse
por: Al-Temaimi, Rabeah A., et al.
Publicado: (2016)

CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtype
por: Tan, Tuan Zea, et al.
Publicado: (2015)

Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
por: Tan, Tuan Zea, et al.
Publicado: (2014)

An novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma
por: Pan, Jian, et al.
Publicado: (2011)

Sphingosine Kinase-1 (SphK-1) Regulates Mycobacterium smegmatis Infection in Macrophages
por: Prakash, Hridayesh, et al.
Publicado: (2010)

Pathological roles of the VEGF/SphK pathway in Niemann–Pick type C neurons
por: Lee, Hyun, et al.
Publicado: (2014)

HJURP Promotes Epithelial-to-Mesenchymal Transition via Upregulating SPHK1 in Hepatocellular Carcinoma
por: Chen, Tianchi, et al.
Publicado: (2019)

Links between accelerated replicative cellular senescence and down-regulation of SPHK1 transcription
por: Kim, Min Kyung, et al.
Publicado: (2019)

Increased SPHK1 and HAS2 Expressions Correlate to Poor Prognosis in Pancreatic Cancer
por: Yu, Mengsi, et al.
Publicado: (2021)

Clinical relevance of CERK and SPHK1 in breast cancer and their association with metastasis and drug resistance
por: Bhadwal, Priyanka, et al.
Publicado: (2022)

HOXC11 drives lung adenocarcinoma progression through transcriptional regulation of SPHK1
por: Peng, Xin, et al.
Publicado: (2023)

ATF3 regulates SPHK1 in cardiomyocyte injury via endoplasmic reticulum stress
por: Chen, Huiling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a5lg9401hviifr34rk8re929jd